Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]
Al Shaer NSH +5 more
europepmc +1 more source
Systemic multiple thrombosis caused by double homozygous mutations of PAI-1 4G/4G and MTHFR C677T during pregnancy. [PDF]
Pan H +5 more
europepmc +1 more source
Plasmin-Plasminogen System and Milk Physicochemical Traits in Intensively Reared Chios and Frizarta Ewes: Effects of Lactation Stage, Age, and Somatic Cell Count. [PDF]
Kalogianni AI +4 more
europepmc +1 more source
Tissue Plasminogen Activator as an Approved Strategy for Ischemic Stroke: A Review of tPA's Structure, Mechanism of Action and the Novel Targeting Methods. [PDF]
Didehvar K +4 more
europepmc +1 more source
M1 protein from group A <i>Streptococcus</i> affects fibrin clot formation, structure, and fibrinolytic potential. [PDF]
Cherrington S +4 more
europepmc +1 more source
Role of Clot Formation and Plasminogen Activation in Lower Urinary Tract Pathologies. [PDF]
Molina JJ, Flores-Mireles AL.
europepmc +1 more source
Plasminogen activator activity in tears after excimer laser photorefractive keratectomy [PDF]
Berta, András +5 more
core
Advances in the Research of Hypoxia-Inducible Factor-1Alpha and Plasminogen Activator Inhibitor-1 in Vascular-Related Diseases. [PDF]
Xu X, Ge XH.
europepmc +1 more source
Influence of LDL cholesterol and Lp(a) on monocytes and macrophages in atherosclerosis. [PDF]
Ugovšek S +3 more
europepmc +1 more source
From inhibition to regulation: serpins in health and disease. [PDF]
Kattner AA.
europepmc +1 more source

